Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Genmab
Genenta Science
Ocellaris Pharma, Inc.
NiKang Therapeutics, Inc.
NuCana plc
Shanghai PerHum Therapeutics Co., Ltd.
Sumitomo Pharma America, Inc.
University of Wisconsin, Madison
Novartis
Aravive, Inc.
Genmab
4D pharma plc
Nektar Therapeutics
Roswell Park Cancer Institute
Apollomics (Australia) Pty. Ltd.
Calithera Biosciences, Inc
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Tracon Pharmaceuticals Inc.
Rexahn Pharmaceuticals, Inc.
Western Regional Medical Center
University of Kansas Medical Center
Duke University
The Methodist Hospital Research Institute
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)